Small caption (shown next to Page Title)
About Archer Pharmaceuticals, Inc.
Archer Pharmaceuticals, Inc. (Archer) was founded in 2008 and specializes in targeted drug discovery for Alzheimer’s disease. It is devoted to understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders, and currently has an ongoing clinical trial in Europe for their product Nilvadipine (NILVAD). Archer was created based on the groundbreaking research conducted at the Roskamp Institute in Sarasota, Florida.